Spectral AI Inc. (MDAI)
| Bid | 1.48 |
| Market Cap | 31.77M |
| Revenue (ttm) | 32.44M |
| Net Income (ttm) | -13.23M |
| EPS (ttm) | -0.63 |
| PE Ratio (ttm) | -2.37 |
| Forward PE | -2.64 |
| Analyst | Buy |
| Ask | 1.52 |
| Volume | 1,686,967 |
| Avg. Volume (20D) | 920,391 |
| Open | 1.57 |
| Previous Close | 1.70 |
| Day's Range | 1.41 - 1.59 |
| 52-Week Range | 0.82 - 3.25 |
| Beta | 0.42 |
About MDAI
Spectral AI, Inc. operates as an artificial intelligence (AI) company. The company focuses on medical diagnostics for faster and accurate treatment decisions in wound care with applications involving patients with burns and diabetic foot ulcers. Its products include DeepView, a predictive diagnostic device that offers clinicians an objective and immediate assessment of a wound's healing potential prior to treatment or other medical intervention. ...
Analyst Forecast
According to 2 analyst ratings, the average rating for MDAI stock is "Buy." The 12-month stock price forecast is $4.75, which is an increase of 217.73% from the latest price.
Stock ForecastsNext Earnings Release
Analysts project revenue of ... Unlock content with Pro Subscription
4 months ago · seekingalpha.com
Spectral AI, Inc. (MDAI) Q3 2024 Earnings Conference Call TranscriptSpectral AI, Inc. (NASDAQ:MDAI ) Q3 2024 Earnings Conference Call November 6, 2024 5:00 PM ET Company Participants Devin Sullivan - MD of Equity Group Michael DiMaio - Chairman Vincent Capone - CFO Co...